Fish Oil Benefits: What Omega-3 Fatty Acids Actually Do in Your Body

Fish oil has been in the wellness conversation for decades. At some point it became the supplement that everyone’s parents were taking, then the one health influencers were recommending, then the one cardiologists were debating. It occupies a unique space — popular enough that most people have heard of it, studied enough that there’s real evidence to discuss, and complex enough that the evidence is genuinely nuanced.

The most important thing to understand upfront: the fish oil benefits that are well-established are meaningful, but they’re not the same for every condition. Research on fish oil’s effect on cardiovascular disease went through a significant revision in the last decade — and if you’ve seen headlines saying “fish oil doesn’t work for heart disease,” that story is more complicated than the headline implies. Meanwhile, the evidence for fish oil in areas like triglyceride reduction, skin health, eye health, and mood is quite different in character.

This guide covers what the research actually shows for each major area — not a list of promised benefits, but an honest breakdown of where the evidence is strong, where it’s moderate, and where it’s still developing.

Key Takeaways

• High triglycerides: The strongest evidence for fish oil supplementation. EPA+DHA at doses of 2–4 grams/day reduces triglyceride levels by 15–30% — well-established across multiple trials, FDA has approved prescription-strength omega-3s specifically for this use.
• Heart disease: Eating fatty fish twice weekly reduces cardiovascular mortality. Fish oil supplements show more modest and inconsistent effects — the benefit is real but smaller than from dietary fish, likely because supplements don’t replicate the full nutritional profile of whole fish.
• Skin health (omega 3 for skin): EPA and DHA are structural components of the skin’s lipid barrier. Supplementation consistently improves skin hydration and reduces inflammatory skin conditions — one of the more underappreciated fish oil benefits.
• Eye health (omega 3 for eyes): DHA is the dominant structural fatty acid in the retina. Low intake is associated with dry eye symptoms and accelerated age-related macular changes.
• Mood and anxiety (omega 3 anxiety): EPA-predominant omega-3 supplementation shows statistically significant improvements in depressive symptoms across multiple meta-analyses. The effect size is modest but meaningful, particularly for mild to moderate presentations.
• DHA in pregnancy: DHA is actively transferred to the developing fetus during the third trimester. Adequate maternal DHA intake during pregnancy is associated with better infant neurodevelopmental outcomes.

Fish Oil and Heart Disease: The Nuanced Truth

This is where the confusion lives, so it deserves careful treatment.

The research on dietary fish: Consistent and strong. People who eat fatty fish at least twice a week have meaningfully lower rates of fatal cardiovascular events. This finding has held across large observational studies in multiple populations.

The research on fish oil supplements for heart disease: More complicated. Earlier studies suggested clear cardiovascular benefit from supplementation. More recent large randomized controlled trials — including ORIGIN (2012), ASCEND (2018), and VITAL (2018) — found more modest effects. The picture that emerged is that fish oil supplements at typical doses (1 gram/day) provide modest benefit for cardiovascular events in high-risk populations, but don’t replicate the magnitude of benefit seen from regularly eating fish.

Why the difference? This is the part Mayo Clinic’s article doesn’t explain, but it matters. Whole fish contains more than just EPA and DHA — it also provides vitamin D, selenium, taurine, high-quality protein, and other bioactive compounds. Eating fish regularly also tends to replace other foods (often red or processed meat) that themselves increase cardiovascular risk. Fish oil supplements provide EPA and DHA but not the full nutritional context of the food. Additionally, the REDUCE-IT trial (2018) found that high-dose EPA alone (4 grams/day, prescription-strength icosapentaenoic acid) significantly reduced major cardiovascular events in people with elevated triglycerides and existing cardiovascular disease — suggesting that the benefit is real at higher doses and in the right population.

The practical take: Fish oil supplements at typical OTC doses are not a substitute for dietary fish and should not be expected to produce the same cardiovascular protection. For people with high triglycerides or existing cardiovascular risk, higher-dose omega-3s under physician supervision have more robust evidence.

Fish Oil Benefits for Triglycerides: The Strongest Evidence

If there’s one area where fish oil’s evidence is unambiguous, it’s triglyceride reduction.

Multiple well-designed clinical trials consistently show that EPA+DHA supplementation at 2–4 grams/day reduces blood triglyceride levels by approximately 15–30%, dose-dependently. The FDA has approved two prescription omega-3 formulations — Vascepa (icosapentaenoic acid, EPA only) and Lovaza/Epanova (EPA+DHA) — specifically for the treatment of severe hypertriglyceridemia. This is the standard for pharmaceutical evidence.

The mechanism: EPA and DHA reduce the liver’s synthesis of very-low-density lipoprotein (VLDL), which carries triglycerides in the bloodstream. They also increase the activity of enzymes that clear triglycerides from circulation.

For people with elevated triglycerides — particularly above 200 mg/dL — omega-3 supplementation is one of the more evidence-backed nutritional interventions available. This is an area where supplement dosing matters: the 1-gram capsule providing 300 mg of combined EPA+DHA that most people take as standard fish oil is substantially below the doses used in the clinical trials that showed triglyceride reduction.

Omega-3 for Skin: More Evidence Than You Might Expect

This is one of the most underappreciated fish oil benefits, particularly because it affects something people can see and feel directly.

EPA and DHA are components of the phospholipids in skin cell membranes. They’re also precursors to the anti-inflammatory eicosanoids that regulate the skin’s inflammatory response. When EPA and DHA are chronically low, skin barrier function can be subtly compromised — leading to dryness, increased sensitivity, and reduced resilience to environmental stressors.

Skin hydration and barrier function: Several clinical studies have found that omega-3 supplementation improves skin hydration and reduces transepidermal water loss (the rate at which water evaporates through the skin surface). These effects are dose-dependent and tend to emerge over 8–12 weeks of consistent supplementation.

Inflammatory skin conditions: EPA in particular has documented anti-inflammatory effects in skin tissue. Studies in people with atopic dermatitis (eczema) have found that omega-3 supplementation reduces symptom severity — though the effects are modest and adjunctive rather than curative. The anti-inflammatory mechanism (EPA competing with arachidonic acid for inflammatory eicosanoid production) helps explain why the benefit is real but limited.

Sun protection (not a substitute for sunscreen): Some research suggests that EPA may increase the skin’s resistance to UV-induced damage by modulating the inflammatory response to UV exposure. This is a supportive effect, not sun protection — it doesn’t replace sunscreen or reduce burn risk.

Omega 3 skin benefits for acne: The anti-inflammatory pathway also offers a theoretical basis for benefit in acne — inflammatory lesions involve similar eicosanoid-mediated processes. Some small studies have found modest improvements in acne severity with omega-3 supplementation. Evidence here is preliminary, but the mechanism is sound.

Omega-3 for Eyes: What DHA Does in the Retina

DHA is the dominant omega-3 fatty acid in the retina — specifically in the photoreceptor outer segments of the rod and cone cells that convert light into neural signals. Its structural properties (long chain, high degree of unsaturation) make it particularly suited to the highly fluid, rapidly responding membranes of retinal cells.

Dry eye syndrome: Multiple clinical trials have found that omega-3 supplementation reduces dry eye symptoms — improving tear production, reducing tear osmolarity, and alleviating the grittiness and discomfort that come from inadequate tear film. A 2013 meta-analysis of 17 studies found significant improvement in dry eye symptoms with omega-3 supplementation. The effect is most relevant in people spending extended hours in front of screens (which reduces blink rate and accelerates tear evaporation) and those in air-conditioned environments.

Age-related macular degeneration (AMD): Observational studies consistently show that higher dietary DHA and EPA intake is associated with reduced risk of progression to advanced AMD. The mechanism involves DHA’s structural role in photoreceptor membranes and EPA’s anti-inflammatory effects in retinal tissue. The AREDS2 trial, which evaluated nutrient supplementation in AMD, included omega-3s but did not show additional benefit beyond the AREDS formulation — a nuanced finding that suggests omega-3s may be more relevant in prevention than in treating established AMD.

DHA in Pregnancy: Why It Matters for Fetal Brain Development

DHA is actively transported across the placenta during pregnancy, with particularly rapid accumulation in the fetal brain during the third trimester — the period of most rapid neural development. This placental transfer preferentially directs DHA to the fetus, which can draw significantly from maternal stores if dietary intake isn’t sufficient.

The evidence for maternal DHA supplementation: Multiple randomized trials have found that supplementing DHA during pregnancy is associated with better infant neurodevelopmental outcomes — specifically, performance on assessments of visual acuity, cognitive development, and language. A 2019 meta-analysis in Prostaglandins, Leukotrienes and Essential Fatty Acids found that maternal DHA supplementation was associated with significantly higher infant DHA status at birth, though the strength of developmental outcome associations varied by study.

The practical recommendation: The European Commission recommends 200 mg DHA/day above regular intake during pregnancy and lactation. Many prenatal vitamins now include DHA. For women who don’t eat fatty fish at least twice weekly, algal oil (the vegan/vegetarian DHA source) provides an equivalent option.

A nuance worth noting: The developmental benefit of maternal DHA is most pronounced when correcting inadequate baseline intake — not from supplementing well above an already-adequate level. Like most nutrients, the marginal benefit diminishes as status improves.

Omega-3 and Anxiety: What the Research Shows

The relationship between omega-3 fatty acids and mood/anxiety is one of the most actively researched areas — and also one of the most frequently overstated in wellness content.

The honest picture on depression: A 2019 meta-analysis in Translational Psychiatry (Liao et al.) analyzed 26 randomized controlled trials and found that omega-3 supplementation produced a statistically significant reduction in depressive symptoms, with EPA-predominant formulations (>50% EPA) showing larger effects than DHA-predominant formulations. Effect sizes were modest (meaning the benefit is real but not large), and the benefit was most pronounced in people with diagnosed depressive conditions, with less consistent effects in healthy populations.

Anxiety specifically: The evidence is somewhat thinner than for depression. A 2018 meta-analysis found significant reductions in anxiety symptoms with omega-3 supplementation at doses ≥2 grams/day. The mechanism likely involves EPA’s role in reducing neuroinflammation (an increasingly recognized factor in mood disorders) and DHA’s structural contribution to neurotransmitter receptor function.

Editorial perspective: Omega-3s are not an anxiety treatment. But the neurobiological rationale is sound, the evidence is directionally consistent, and the risk profile is favorable. For someone dealing with mild mood disruption who also isn’t getting adequate omega-3s, this is a reasonable place to address nutritional gaps — alongside, not instead of, professional evaluation.

Fish Oil Brain Health Benefits: Cognition and Aging

The most studied omega-3 brain health claim relates to cognitive aging and dementia prevention. DHA is the dominant structural omega-3 in neural tissue, comprising a significant proportion of the phospholipid membranes in neurons and synaptic endings. Lower DHA status is consistently associated with faster cognitive decline in aging populations.

Where the evidence is compelling: Higher lifetime omega-3 intake is associated with larger brain volume and slower cognitive decline in observational studies. In people with mild cognitive impairment, some intervention trials have found benefits for memory and executive function with omega-3 supplementation.

Where the evidence is less clear: Large RCTs in cognitively healthy adults have produced inconsistent results — suggesting the benefit may be most relevant in preventing decline when it’s starting to occur, rather than as a general cognitive enhancer in healthy people.

The practical framing: DHA is a maintenance nutrient for brain tissue, not a cognitive stimulant. Getting adequate omega-3s consistently over time is more about supporting the structural integrity of neural tissue than producing acute cognitive effects.

Who Benefits Most from Fish Oil Supplements?

Given that “eat more fatty fish” is consistently better advice than “take supplements” for many outcomes, the more useful question is: who should supplement specifically?

Strong case for supplementation:

• People with elevated triglycerides (above 200 mg/dL) — this is where supplement doses above 2 grams/day EPA+DHA have the strongest evidence
• People with rheumatoid arthritis — studies show modest but meaningful reductions in joint pain and morning stiffness
• Pregnant and breastfeeding women who don’t eat fatty fish twice weekly — DHA transfer to the fetus is a specific and documented need
• People with dry eye symptoms, particularly screen workers and contact lens wearers

Reasonable case for supplementation:

• People who don’t eat fatty fish and have no plans to start — supplements provide EPA and DHA that diet is not delivering
• Vegans and vegetarians (algal oil specifically) — no fish option, and ALA conversion to EPA/DHA is limited
• People with mild mood concerns alongside low omega-3 dietary intake

Weaker case (fish is the better answer):

• Primary cardiovascular prevention in healthy adults — eating fish twice weekly is more effective than supplementing
• General cognitive enhancement in healthy, well-nourished adults — insufficient evidence at typical doses

Safety, Side Effects, and What to Watch For

Fish oil at standard doses (1–3 grams/day of total fish oil) is generally well tolerated. The most common side effects:

The fishy aftertaste and burping: The most complained-about side effect. Solutions that actually work: enteric-coated capsules (dissolve in the small intestine rather than the stomach), taking with food, keeping capsules in the freezer. Not all brands produce this equally — higher-quality, less oxidized oils tend to produce fewer burps.

Digestive discomfort: Nausea, loose stools, and heartburn occur in some people, particularly at higher doses. Taking with a meal helps significantly.

Blood thinning at high doses: EPA and DHA have mild antiplatelet effects. At prescription doses (4 grams/day), this is clinically significant enough that REDUCE-IT participants had slightly higher rates of bleeding events. At standard OTC doses (1–3 grams), the effect is minor for most healthy adults. If you’re on anticoagulant medications (warfarin, aspirin therapy, clopidogrel), discuss fish oil supplementation with your prescribing physician.

Oxidation and quality: Fish oil oxidizes when exposed to light, heat, and air — and oxidized fish oil may have reduced efficacy and potentially adverse effects. Signs of oxidized oil: strong fishy smell even before opening, unpleasant rancid taste. Refrigerating after opening, checking expiration dates, and choosing third-party tested products reduce this risk.

Mercury: Fish themselves accumulate mercury, but fish oil supplements undergo purification during manufacturing that removes mercury and other heavy metals. Reputable fish oil supplements contain no detectable mercury — this is one area where supplements are actually safer than the whole food source.

Frequently Asked Questions

What are the main fish oil benefits? The best-established fish oil benefits are triglyceride reduction (15–30% at therapeutic doses), modest improvements in blood pressure, joint pain and morning stiffness reduction in rheumatoid arthritis, improved skin hydration and barrier function, reduced dry eye symptoms, and support for fetal brain development during pregnancy. Evidence for mood support and cognitive health is emerging and directionally consistent.

Does fish oil actually help your heart? Eating fatty fish twice weekly is strongly associated with reduced cardiovascular mortality. Fish oil supplements show more modest and inconsistent effects on heart disease outcomes at typical OTC doses. High-dose, prescription-strength EPA (4 grams/day) significantly reduced cardiovascular events in people with high triglycerides and existing cardiovascular disease in the REDUCE-IT trial. For most healthy adults, the priority is dietary fish, not supplements.

What does omega-3 do for your skin? EPA and DHA are structural components of skin cell membranes and support the skin’s lipid barrier function. Supplementation consistently improves skin hydration, reduces transepidermal water loss, and may reduce the severity of inflammatory skin conditions like eczema. Effects typically emerge over 8–12 weeks of consistent supplementation.

Is fish oil good for your eyes? DHA is the dominant structural fatty acid in the retina. Low omega-3 intake is associated with dry eye symptoms and increased risk of age-related macular changes. Multiple clinical trials support omega-3 supplementation for reducing dry eye symptoms. Evidence for AMD prevention is supportive but most relevant in the preventive context.

Can omega-3 help with anxiety? A 2018 meta-analysis found statistically significant reductions in anxiety symptoms with omega-3 supplementation at doses ≥2 grams/day. EPA-predominant formulations appear to have larger effects on mood-related outcomes. The evidence is real but modest — omega-3s are not a treatment for anxiety disorders, but they’re a reasonable nutritional consideration for people with mild mood concerns and low omega-3 intake.

How much omega-3 do I need per day? The NIH’s Adequate Intake for ALA (the plant-based omega-3) is 1.1–1.6 grams/day for adults. For EPA and DHA specifically, no official RDA exists — but most researchers suggest 500 mg/day of combined EPA+DHA for general health maintenance, and 2–4 grams/day for therapeutic purposes (triglyceride reduction, clinical anti-inflammatory doses). Standard OTC fish oil capsules typically provide 300 mg combined EPA+DHA per capsule.

The Bottom Line

Fish oil benefits are real — but they’re condition-specific, dose-dependent, and in some cases more modest than popular accounts suggest. The strongest evidence is for triglyceride reduction and joint inflammation in rheumatoid arthritis. The evidence for skin, eyes, mood, and fetal development is meaningful and growing. The evidence for cardiovascular disease prevention is real but most relevant to dietary fish intake, not necessarily supplementation at standard doses.

The most honest framing: omega-3 fatty acids are essential nutrients that many people in Western diets don’t get enough of. Addressing that gap — through food or supplements — is worthwhile. Expecting fish oil to function as a pharmaceutical treatment for any single condition is likely to lead to disappointment.

Want to understand the difference between EPA, DHA, and ALA — and which one matters most for your specific goals? EPA vs. DHA: What’s the Difference and Which Do You Need? (C3)

Comparing fish oil, krill oil, and algae oil? Our guide breaks down the differences in absorption, sustainability, and who each form is best for: Fish Oil vs. Krill Oil vs. Algae Oil: How to Choose (C4)

References

1. National Institutes of Health Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals. Updated May 2026. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
2. Bhatt DL, Steg PG, Miller M, et al. Cardiovascular Risk Reduction with Icosapentaenoic Acid for Hypertriglyceridemia (REDUCE-IT). New England Journal of Medicine. 2019;380(1):11-22. doi:10.1056/NEJMoa1812792
3. Liao Y, Xie B, Zhang H, et al. Efficacy of omega-3 PUFAs in depression: A meta-analysis. Translational Psychiatry. 2019;9(1):190. doi:10.1038/s41398-019-0515-5
4. Su KP, Tseng PT, Lin PY, et al. Association of Use of Omega-3 Polyunsaturated Fatty Acids With Changes in Severity of Anxiety Symptoms. JAMA Network Open. 2018;1(5):e182327. doi:10.1001/jamanetworkopen.2018.2327
5. Kawashima H. Intake of arachidonic acid-containing lipids in adult humans: dietary surveys and clinical trials. Lipids in Health and Disease. 2019;18(1):101. doi:10.1186/s12944-019-1041-4
6. Mayo Clinic. Fish Oil. January 21, 2026. https://www.mayoclinic.org/drugs-supplements-fish-oil/art-20364810